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1. Introduction 
Botulinum neurotoxin (BoNT) produced by an anaerobic bacterium Clostridium botulinum 
causes highly fatal disease called botulism. BoNT is a zinc-dependent metalloprotease [1] 
with a molecular mass of 150 kDa, and classified into seven distinct serotypes A through G. 
Serotype A, B, E and F BoNTs dominantly cause human botulism, whereas serotype C and D 
BoNTs are the causative substance of the animal and avian botulism [2,3]. The BoNT invades 
into the human or animal body via one of three ways; toxin production by the bacterium 
colonized on the digestive tract in early childhoods (infant botulism), entrance of the toxin 
from the wound (wound botulism), and the oral ingestion of the toxin-contaminated foods 
(food-borne botulism). The food-borne botulism is the most frequent among the three cases. 
In any of these cases, the BoNT ultimately reaches the neuromuscular junction and enters 
nerve cell via receptor-mediated endocytosis. Once in the nerve cell, the metalloprotease 
activity of the toxin cleaves the specific site on the target proteins associated with the 
intracellular vesicle transport, such as synapse-associated protein of molecular weight 25,000 
(SNAP-25; serotypes A, C and E), syntaxin (serotype C) and vesicle-associated membrane 
protein (VAMP; serotypes B, D and F), and inhibits the release of acetylcholine to 
extracellular space [2,4,5]. These process cause muscular paralysis in humans and animals. 
When pure BoNT is exposed to the digestive conditions with acidic fluid and proteases, the 
BoNT easily degrades into inactive short peptides [6-15] and thus the pure BoNT exerts the 
only weak or no oral toxicity. This implies that the pure BoNT seems unlikely to cause the 
food-borne poisoning, and conflicts with the previous description that the food-borne 
botulism is the most frequent among three botulism diseases. The answer that resolves this 
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discrepancy is the toxin complex (TC). In the culture supernatant and polluted foods, the 
BoNT is a part of the TC. Serotype A–D strains produce both of hemagglutination-negative 
and -positive TC, whereas serotype E and F strains produce only hemagglutination-negative 
TC. The hemagglutination-negative TC is 280-kDa M-TC consists of BoNT and nontoxic 
nonhemagglutinin (NTNHA). On the other hand, hemagglutination-positive TC is 750-kDa 
L-TC composed of M-TC and three types of hemagglutinins (HAs; HA-70, HA-33 and HA-
17). Serotype A strain produces additional LL-TC, which might be a dimer of L-TC [16,17].  
The oral toxicities of the M-TC, L-TC and LL-TC are much greater than pure BoNT. 
Therefore it seems that the auxiliary nontoxic proteins play a role for the delivery of the 
toxin through the animal digestive system so that the botulinum TC exerts the oral toxicity. 
In our chapter, we describe our findings in the series of studies on the structure and function 
of botulinum TC, especially focused on the nontoxic proteins NTNHA and HAs. 
2. Assembly pathway of botulinum toxin complex 
On the genome of the C. botulinum strains, the gene encoding BoNT forms one or two gene 
clusters along with other genes (Figure 1) [16,18-22]. In serotypes A–D, cluster 1 contains the 
genes coding the BoNT and NTNHA, whereas the cluster 2 contains three genes coding 
HAs. The open reading frames of the genes on the cluster 2 run opposite orientation against 
those on the cluster 1. Serotypes E and F lack cluster 2. In the serotypes C and D, the gene 
designated as botR is located on the downstream of the cluster 2 with opposite directions to 
reading frames of HA genes. Similar genes are also found in the serotypes A and B, and they 
are located between the cluster 1 and 2. The gene products of botR do not participate as a 
constituent of the TC, but control the expression of the genes on the cluster 1 and 2 [23,24]. 
 
Figure 1. Genetic organization of botulinum neurotoxin related genes of C. botulinum. This scheme 
indicates the BoNT gene clusters in serotype A–F strains. Botulinum TCs are encoded by two gene 
clusters; cluster 1 encodes BoNT (bont) and NTNHA (ntnha), and cluster 2 encodes three HAs (ha-70, ha-
17 and ha-33). Each gene cluster is transcribed polycistronically, as indicated by arrows. Genetic 
organization of serotype A resembles that of serotype B. Similarly, gene organizations of serotype C and 
D BoNT clusters are much alike. On the other hand, serotypes E and F do not possess any HA gene. The 
gene product of botR controls the expression of the genes on the cluster 1 and 2. In serotypes E and F, 
p47 gene is arranged sequentially in the upstream region of the bont gene cluster and its gene product 
has been uncharacterized. 
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Although the C. botulinum serotype C and D strains hold five genes involved in the TC 
constituents, they produces two types of TCs, M-TC (a complex of BoNT and NTNHA) and 
L-TC (a complex of M-TC and HAs). Ever since the discovery of TC produced by C. 
botulinum strains, discrepancy in the coexistence of two types of the TCs in the same culture 
had been a longstanding mystery. In the culture supernatant, the 150-kDa BoNT of the L- 
and M-TC are split into a 50-kDa light chain (Lc) and a 100-kDa heavy chain (Hc) by the 
excision of several amino acid residues [25], and the HA-70 in the L-TC is also split into 22–
23-kDa and 55-kDa fragments by proteolytic processing after translation [26]. The NTNHA 
of the M-TC is always found nicked at their N-terminus leading to a 15-kDa N-terminal 
fragment and a 115-kDa C-terminal fragment, whereas the NTNHA of the L-TC remains 
intact [20,27]. Thus, the components of the TCs are nicked, leading to the appearance of 
many fragments on the SDS-PAGE. This may complicate the consideration of botulinum TC 
structure, and hamper the resolution of the discrepancy in coexistence of dual form of TC. 
In 2002, we finally found one of the answers to solve this discrepancy [28]. Before that, we 
needed two breakthroughs to find the answer. First, we serendipitously found a unique 
serotype D strain 4947 (D-4947), producing the M-TC and L-TC without any nicking in the 
components of the complex. Second, we have established the method to isolate viable HA 
components (HA-70, HA-33/HA-17 complex) from the L-TC in the presence of 4 M 
guanidine hydrochloride [29]. By using the M-TC (BoNT/NTNHA) and isolated HA-70 and 
HA-33/HA-17 without any nicking obtained from serotype D-4947 strain, we performed 
reconstitution experiments to construct the L-TC (Figure 2) [28]. Mixture of the M-TC and 
HA-70 yielded a de novo M-TC/HA-70 complex, whereas a mixture of the M-TC and HA-
33/HA-17 did not produce any complex. Further the M-TC/HA-70 complex converted to the 
mature L-TC by mixing with the HA-33/HA-17. On the other hand, M-TC, which contained 
nicked NTNHA prepared by treatment with exogenous trypsin, could no longer be 
reconstituted to mature L-TC with HA subcomponents, whereas the L-TC treated with 
trypsin was not degraded into M-TC and HA subcomponents. Consequently, we concluded 
that the association of BoNT and NTNHA produces M-TC, and thereafter is converted to the 
L-TC by assembly with HA-70 and HA-33/HA-17.  
3. Subunit structure of botulinum toxin complex with three extended 
arms 
C. botulinum serotype C and D strains produce 280-kDa M-TC and 750-kDa L-TC. In 
addition to these TCs, we found three intermediate TC species in the culture supernatants of 
serotype C and D strain [30,31]. One of them is M-TC/HA-70 complex (490 kDa). Remaining 
two is 610- and 680-kDa TC, corresponding to the intermediate products in the pathway 
leading from the 490-kDa M-TC/HA-70 to the mature 750-kDa L-TC, which has a smaller 
number of HA-33/HA-17 complexes than mature L-TC. All of the TC species, except for the 
750-kDa L-TC, demonstrated no hemagglutination activity. When the intermediate TC 
species were mixed with an isolated HA-33/HA-17 complex, all TC species were maturated 
to 750-kDa L-TC with full hemagglutination activity and had the same molecular 
composition of native 750-kDa L-TC [30]. Therefore, these findings indicated that the mature 
L-TC contains multiple HA-33/HA-17 sub-complexes.  
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Figure 2. Proposed model for the botulinum toxin complex assembly pathway. Genetic organization 
of botulinum serotype C and D TCs and their expressed products are represented based on nucleotide 
sequences and N-terminal amino acid sequences. The assembly pathway from each gene product and 
proteolytic pathway is indicated by solid and dotted arrows, respectively. The upper panel represents 
the assembly pathway of the components to TCs, and the middle panel represents putative proteolytic 
pathway of the nicked TCs usually observed in serotype C and D strains. The lack of mutual conversion 
between L- and M-TC is represented by the X symbol. The lower panel represents dissociation and 
reassembly of the TCs depending on pH 
To characterize the HA-33/HA-17 complex, we determined the X-ray crystal structure of the 
isolated HA-33/HA-17 complex from D-4947 L-TC at 1.85 Å resolution [17]. As shown in 
Figure 3, the final model of the complex includes two HA-33 molecules and one HA-17 
molecule in the asymmetric unit. This model is consistent with the molecular composition of 
HA-33/HA-17 complex as determined from molecular mass of the complex by nanoLC/ESI-
TOF-MS yielded a mass of 84,118 Da (calculated molecular mass of two HA-33 plus one HA-
17 is 84,239 Da).  
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Figure 3. Crystal structure of the HA-33/HA-17 trimer complex. (a) Structure of HA-33/HA-17 trimer 
complex isolated from serotype D-4947 L-TC as represented by a ribbon diagram. (b) Surface 
representation of HA-33/HA-17 trimer complex: HA-33 molecules in blue and HA-17 molecule in cyan. 
Figures were prepared using MolFeat version 3.0 (FiatLux Corp.). The crystal structure of HA-33/HA-17 
trimer complex was resolved at 1.85 Å. 
To clarify the TC structure, the purified TC species, i.e. M-TC, M-TC/HA-70, and 610-, 680- and 
750-kDa L-TC, were visualized by negative stained transmission electron microscopy (TEM) 
[17] (Figure 4). As a result, the M-TC (BoNT/NTNHA) appears as an approximately 13-nm 
spherical or ellipsoidal particle. The M-TC/HA-70 displayed an acorn-like shape with the HA-
70 “cone” lying on the M-TC. Interestingly, the 610- and 680-kDa TC and mature 750-kDa L-
TC revealed unique “arm” attachments that displayed to be rod-like structure. Number of the 
arm (approximately 10 nm length) in the TCs was one, two and three for the 610- and 680-kDa 
TC and mature 750-kDa L-TC, respectively. We concluded that the arm-like structure is the 
HA-33/HA-17 that attached to the M-TC/HA-70 complex via HA-70 molecule. At this point,  
 
Figure 4. Electron micrographs of the botulinum serotype D-4947 TC species. The upper panel 
represents the TCs [M-TC, M-TC/HA-70, and one-, two- and three-arm L-TCs, respectively]. Scale bar in 
the upper left panel indicating 10 nm applies to all panels. The middle panel represents tracing of 
images of the subunit components: BoNT in red, NTNHA in green, HA-70 in yellow and HA-33/HA-17 
complex in blue. A black spot, which is assumed to be a zinc atom or cavity, is indicated by the circle 
with an arrow in each BoNT image. The lower panel represents corresponding schematic structure 
model of each TC.  
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the number of the HA-70 molecule in the L-TC is still unclear. Therefore, we examined a 
densitometric analysis of Coomasie Brilliant blue staining bands on SDS-PAGE gels to 
understand the number of the HA-70 molecule in the complex. The result indicated that the 
number of the molecule is three. After our report regarding the number of the HA-70 molecule 
in the L-TC, the X-ray crystallographic structure of the HA-70 was published [32]. They 
displayed a three-leaved propeller-like structure, which is consistent with our experiment.  
After the TEM observations of the TCs, we named the 610- and 680-kDa TC and mature 750-
kDa L-TC, as one-, two- and three-arm L-TC [33]. Based on the TEM images and the 
crystallographic structure of the HA-33/HA-17, we constructed a 14-heteromer model of the 
mature three-arm L-TC [17]. That is, the three-arm L-TC is composed of a single BoNT 
molecule, a single NTNHA molecule, and an HA complex. The HA complex is comprised of 
three HA-70 molecules and three arm structure of HA-33/HA-17 that consists of two HA-33 
molecules and a single HA-17 molecule (Figure 5). This model suggests that the six HA-33 
molecules exposed to outer of the mature three-arm L-TC, where they play a role in 
anchoring the complex at the epithelial cell surface. 
 
Figure 5. Subunit structure of the botulinum large toxin complex (L-TC). L-TC possesses 14-mer 
subunit structure and is composed of five types of protein; BoNT, NTNHA and three types of HAs. 
BoNT molecule is shown in red, NTNHA in green, HA-70 in yellow, HA-33 in blue and HA-17 in cyan, 
respectively. 
4. Botulinum toxin complex resistant to proteolytic digestion 
BoNT dissociates from the botulinum TC under the alkaline condition, while under the 
acidic condition the BoNT re-associates with the nontoxic component complex generating 
the L-TC. Botulinum TC exerts the grater oral toxicity than BoNT detached from the 
complex. Thus the nontoxic components play a vital role to exert the oral toxicity of the 
botulinum TC. Of the nontoxic components of the botulinum TC, the NTNHA displays 
unique property. That is, the NTNHA components in both isolated form and the M-TC 
(BoNT/NTNHA) complexed form are spontaneously converted to the nicked form leading 
15-kDa N-terminal and 115-kDa C-terminal fragments with excision of several amino acid 
residues at specific sites during long-term incubation [34]. To clarify the role of the NTNHA 
on oral toxicity of the TC, we constructed the overexpression system that produces the 
recombinant NTNHA (rNTNHA) in the Escherichia coli strain [15]. The NTNHA gene was 
amplified by the PCR using the gene specific primer, ligated to pET200-D/TOPO, and then 
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transformed into a large-scale E. coli BL21 cell expression system to produce the rNTNHA 
with His-tagged N-terminus. The rNTNHA was also spontaneously converted to nicked 
form during long-term incubation generating N-terminal 18-kDa N-terminal (containing 
His-tag) and 115-kDa C-terminal fragments. Using the rNTNHA, crystallization and 
preliminary X-ray analysis was successfully performed [35]. Further the rNTNHA was 
successfully reconstituted with isolated BoNT generating M-TC by mixing these proteins at 
a molar ratio 1:1 followed by incubation at pH 6.0. The reconstituted M-TC reversibly 
dissociated into rNTNHA and BoNT at pH 8.8. During reconstitution experiment, the intact 
rNTNHA in the reconstituted M-TC was spontaneously converted into nicked form 
indicated by the 18- and 115-kDa bands on the SDS-PAGE. These features including 
spontaneous cleavage occurred in the molecule and reconstitution with the BoNT are 
consistent with those of the native NTNHA.  
During the oral delivery of the botulinum TC, the orally ingested TC is exposed to acidity 
and proteolysis in the gastrointestinal tract. To examine the stability of the rNTNHA, BoNT 
and reconstituted M-TC, these proteins were exposed to harsh conditions mimicking 
environment of the stomach (30 U pepsin in pH 2.7) and small intestine (1250 U trypsin in 
pH 6.0) (Figure 6). The rNTNHA was digested into several fragments after incubation with 
pepsin for 60 min, whereas trypsin treatment for 360 min yields just nicking in rNTNHA. 
The BoNT was highly sensitive to both trypsin and pepsin digestion, producing no bands on 
the SDS-PAGE. In contrast, when the BoNT formed complex with rNTNHA generating the 
reconstituted M-TC, both proteins exhibited amazing resistance to proteolysis. When the 
reconstituted M-TC was treated with the pepsin, the BoNT displayed no sign of the 
fragmentation, while the rNTNHA was converted to nicked form yielding 18- and 115-kDa 
fragments on the SDS-PAGE. Trypsin treatment of the M-TC produced specific nicked form 
BoNT and rNTNHA. Because only the reconstituted M-TC displayed high tolerance against 
both trypsin and pepsin attacks, we presumed that the NTNHA component can alter its 
conformation to assemble with BoNT, forming an oral toxin that protects BoNT from harsh 
conditions in the digestive tract. The presumption was certified very recently by the X-ray 
crystal structure of serotype A M-TC [36].  
 
Figure 6. Stability of BoNT, NTNHA and M-TC (BoNT/NTNHA complex) to protease attack. Both 
BoNT and NTNHA molecules in free form are easily degraded by protease attack, while both proteins 
in M-TC shows the resistance to pepsin and trypsin. These protease tolerance represents the NTNHA 
could protect BoNT from protease attack in the digestive tract. 
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5. HA-33 facilitates transport of toxin complex across intestinal epithelial 
cell monolayer 
For the oral delivery, not only the acidity and proteases in the digestive tract, the physical 
barrier presented by the intestinal wall is also large obstacle. Of the nontoxic components of 
the botulinum TC, HA-33 component exposed outermost of the complex, and possesses an 
ability to recognize sugar chains on intestinal microvilli. Additionally a series of the 
investigations indicated that the L-TC containing HA-33 components transports across the 
intestinal epithelial cell monolayer more effectively than pure BoNT [14,37,38]. Therefore the 
HA-33 component appears to play a role in the transport of the TC across the intestinal 
epithelium. However, some serotype A and serotype E and F strains do not possess the genes 
that encode the HA components [18,39,40], implying that the absorption of the botulinum TC 
into intestinal epithelial cells does not depend on the presence of HA components. 
In the study of [33], BoNT, M-TC (BoNT/NTNHA), M-TC/HA-70 and three types of L-TC  
(one-, two- and tree-arm L-TC) with different numbers of the HA-33/HA-17 arm attached were 
purified from the culture of the D-4947, to examine the cell binding and monolayer transport 
of serotype D toxins in the rat intestinal epithelial cell line IEC-6. The TCs including pure 
BoNT were incubated with IEC-6 cells at 4 ˚C for 1 h. Toxins bound to the cells and 
cytoskeletal actins were visualized by immunohistochemistry using anti-BoNT and phalloidin 
(Figure 7a). As a result, fluorescence from the BoNT-, M-TC- and M-TC/HA-70-treated cells 
demonstrated similar intensities, whereas higher intensities were observed after cells were 
treated with one-, two- or three-arm L-TCs. To quantitatively assess binding of the TCs, toxins 
bound to the cells were extracted into the sample buffer containing SDS, applied to SDS-PAGE 
and subjected to Western blot analysis using anti-BoNT. Staining intensities were compared to 
determine the relative amount of the toxins bound to the cells (Figure 7b). BoNT, M-TC and 
M-TC/HA-70 displayed similar cell-binding potencies. In contrast, the one-, two- and three-
arm L-TCs exhibited two, four and five times greater binding than pure BoNT.  
Toxin transport through the IEC-6 cell monolayer was examined using the Transwell two-
chamber system. Toxins suspended in the medium were applied to apical side of the cell 
monolayer. After 1 to 48 h incubation at 37 ˚C, toxins transported through the cell layer were 
collected from the basal side of the layer, applied to SDS-PAGE and then detected by 
Western blot analysis using anti-BoNT, anti-NTNHA, anti-HA-70 and anti-HA-33/HA-17 
(Figure 8a). The result indicated all TCs including pure BoNT transported through the IEC-6 
cell monolayer. L-TC demonstrated greater transport potency than the smaller TCs, whereas 
pure BoNT, M-TC and M-TC/HA-70 exhibited similar transport efficiencies at all time points 
(Figure 8b). After a 24-h incubation, the one-, two- and three-arm L-TCs displayed 2, 2.5 and 
3 times greater cell monolayer transport, respectively.  
To determine the responsible components on the cell binding and cell monolayer transport, 
pure BoNT, M-TC, M-TC/HA-70 and three-arm L-TC were preincubated with one of the 
antibodies against their constituents before binding or transport assay (Figure 9). The 
binding and transport of the pure BoNT were significantly inhibited by preincubation with 
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anti-BoNT. Binding and transport of M-TC was significantly inhibited by anti-BoNT, and 
slightly by anti-NTNHA. As for the M-TC/HA-70, anti-BoNT and anti-HA-70 significantly 
reduced both the binding and transport of the toxin, while anti-NTNHA had very little 
effect. Of the antibodies for three-arm L-TC, the HA-33 significantly interfered with both the 
cell binding and the cell monolayer transport.  
 
Figure 7. Binding of the BoNT and botulinum TCs to IEC-6 cells. (a) Cells were incubated with BoNT, M-
TC, M-TC/HA-70, and one-, two- and three-arm L-TCs at 100 nM for 1 h at 4˚ C. Toxins bound to the cells 
and actins were visualized by immunostaining using BoNT antibody followed by Alexa Fluor 488-
conjugated secondary antibody (green) and Alexa Fluor 546-conjugated Phalloidin (red). Cells without toxin 
treatment was employed as a control. Scale bar indicating 50 µm at upper left panel applies to all images. (b) 
Western blot analysis of the binding of the BoNT and TCs to IEC-6 cells. Cells were incubated with 20 nM 
TCs. To detect the TCs, BoNT in the cell lysate was detected by using anti-BoNT. Representative data (upper 
panel) and calculated relative amounts (lower panel) are shown. The relative amounts of the BoNT were 
calculated based on the intensities of the signals on the Western blot. Double and single asterisk denote a 
significant increase in binding (P<0.01 and P<0.05) compared to the BoNT, respectively. 
 
Figure 8. Transport of the BoNT and botulinum TCs through the IEC-6 cell monolayer. (a) Western 
blot analysis of the transport of TCs through the cell monolayer. Each 20 nM toxin suspension containing 
0.2 mg/ml FITC-dextran (M.W. 500 kDa) was applied to apical side of the cell monolayer. Transported 
TCs through the cell monolayer were collected from the medium in the basal side of the layer, and then 
applied to Western blot analysis. Each component was detected by using corresponding antibody. (b) 
Time course of toxin transport through the cell layer. Toxin concentration in the basal side medium was 
estimated from the band intensities of the BoNT on the Western blot. Amounts of the transported toxins 
are indicated as percentages of the original toxin amounts applied to apical side medium. 
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Figure 9. Effect of antibodies against each TC constituents on the cell binding and cell monolayer 
transport of the botulinum TCs. The toxins (40 nM) were preincubated with antibodies (diluted to 1:10 
in incubation buffer) for 1 h at 37 ˚C before cell binding (upper panel) and cell monolayer transport 
(lower panel) assay. Relative binding and transport were calculated in the same manner for the Figure 8 
and compared with the control without antibody preincubation. Double and single asterisk denote a 
significant increase in binding and transport (P<0.01 and P<0.05) compared to the control.  
Consequently, all TCs including pure BoNT can transport across the intestinal epithelial cell 
monolayer via BoNT, NTNHA, HA-70 and HA-33 depending on the TC structure. 
Nonetheless binding and transport markedly increased with the number of HA-33/HA-17 
arms in the TC. We therefore concluded that the HA-33/HA-17 arm is not necessarily 
required for, but facilitates, transport of the botulinum TC. 
6. Conclusion 
BoNT forms TCs by assembling with nontoxic proteins that include NTNHA and three 
types of HAs. We provide definitive evidence that NTNHA plays a crucial role in protecting 
BoNT, which is an oral toxin, from digestion by proteases common in the stomach and 
intestine. Furthermore, we concluded that the HA-33 is not necessarily required for, but 
facilitates, transport of botulinum TC. In the food-borne botulism poisoning, the nontoxic 
components of the TC play a role as a “delivery vehicle” of the unwanted toxic protein. 
However, we are expecting that the nontoxic proteins would be available for the “delivery 
vehicle” of the drug and vaccine by substituting the BoNT into functional peptides and 
proteins. 
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